Logo image of 5Q5.DE

SNOWFLAKE INC-CLASS A (5Q5.DE) Stock Fundamental Analysis

FRA:5Q5 - Deutsche Boerse Ag - US8334451098 - Common Stock - Currency: EUR

138.88  +2.22 (+1.62%)

Fundamental Rating

4

Taking everything into account, 5Q5 scores 4 out of 10 in our fundamental rating. 5Q5 was compared to 65 industry peers in the IT Services industry. While 5Q5 seems to be doing ok healthwise, there are quite some concerns on its profitability. 5Q5 is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

5Q5 had positive earnings in the past year.
5Q5 had a positive operating cash flow in the past year.
5Q5 had negative earnings in each of the past 5 years.
Of the past 5 years 5Q5 4 years had a positive operating cash flow.
5Q5.DE Yearly Net Income VS EBIT VS OCF VS FCF5Q5.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 0 500M -500M -1B

1.2 Ratios

5Q5 has a Return On Assets of -14.23%. This is amonst the worse of the industry: 5Q5 underperforms 83.08% of its industry peers.
With a Return On Equity value of -42.86%, 5Q5 is not doing good in the industry: 86.15% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -14.23%
ROE -42.86%
ROIC N/A
ROA(3y)-11.57%
ROA(5y)-10.81%
ROE(3y)-24.53%
ROE(5y)-19.6%
ROIC(3y)N/A
ROIC(5y)N/A
5Q5.DE Yearly ROA, ROE, ROIC5Q5.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 -20 -40 -60 -80

1.3 Margins

5Q5's Gross Margin of 66.72% is in line compared to the rest of the industry. 5Q5 outperforms 55.38% of its industry peers.
5Q5's Gross Margin has improved in the last couple of years.
5Q5 does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 66.72%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.25%
GM growth 5Y3.57%
5Q5.DE Yearly Profit, Operating, Gross Margins5Q5.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 0 50 -50 -100 -150

4

2. Health

2.1 Basic Checks

5Q5 does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for 5Q5 remains at a similar level compared to 1 year ago.
The number of shares outstanding for 5Q5 has been increased compared to 5 years ago.
The debt/assets ratio for 5Q5 is higher compared to a year ago.
5Q5.DE Yearly Shares Outstanding5Q5.DE Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
5Q5.DE Yearly Total Debt VS Total Assets5Q5.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

2.2 Solvency

The Debt to FCF ratio of 5Q5 is 2.57, which is a good value as it means it would take 5Q5, 2.57 years of fcf income to pay off all of its debts.
5Q5 has a Debt to FCF ratio of 2.57. This is in the better half of the industry: 5Q5 outperforms 69.23% of its industry peers.
5Q5 has a Debt/Equity ratio of 0.76. This is a neutral value indicating 5Q5 is somewhat dependend on debt financing.
The Debt to Equity ratio of 5Q5 (0.76) is worse than 63.08% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.76
Debt/FCF 2.57
Altman-Z N/A
ROIC/WACCN/A
WACC9.15%
5Q5.DE Yearly LT Debt VS Equity VS FCF5Q5.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B 4B 5B

2.3 Liquidity

A Current Ratio of 1.78 indicates that 5Q5 should not have too much problems paying its short term obligations.
5Q5 has a Current ratio of 1.78. This is amongst the best in the industry. 5Q5 outperforms 81.54% of its industry peers.
A Quick Ratio of 1.78 indicates that 5Q5 should not have too much problems paying its short term obligations.
With an excellent Quick ratio value of 1.78, 5Q5 belongs to the best of the industry, outperforming 83.08% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.78
Quick Ratio 1.78
5Q5.DE Yearly Current Assets VS Current Liabilites5Q5.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B

8

3. Growth

3.1 Past

5Q5 shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -15.46%.
Measured over the past years, 5Q5 shows a very strong growth in Earnings Per Share. The EPS has been growing by 334.45% on average per year.
Looking at the last year, 5Q5 shows a very strong growth in Revenue. The Revenue has grown by 29.21%.
5Q5 shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 68.79% yearly.
EPS 1Y (TTM)-15.46%
EPS 3Y334.45%
EPS 5YN/A
EPS Q2Q%-14.29%
Revenue 1Y (TTM)29.21%
Revenue growth 3Y43.81%
Revenue growth 5Y68.79%
Sales Q2Q%27.37%

3.2 Future

5Q5 is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 40.68% yearly.
Based on estimates for the next years, 5Q5 will show a very strong growth in Revenue. The Revenue will grow by 22.40% on average per year.
EPS Next Y41.19%
EPS Next 2Y40.09%
EPS Next 3Y40.2%
EPS Next 5Y40.68%
Revenue Next Year24.48%
Revenue Next 2Y23.57%
Revenue Next 3Y23.75%
Revenue Next 5Y22.4%

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
5Q5.DE Yearly Revenue VS Estimates5Q5.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 5B 10B 15B
5Q5.DE Yearly EPS VS Estimates5Q5.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 2 4 6 8 10

1

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 192.89, the valuation of 5Q5 can be described as expensive.
69.23% of the companies in the same industry are cheaper than 5Q5, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 28.79. 5Q5 is valued rather expensively when compared to this.
With a Price/Forward Earnings ratio of 136.47, 5Q5 can be considered very expensive at the moment.
5Q5's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. 5Q5 is more expensive than 72.31% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of 5Q5 to the average of the S&P500 Index (21.38), we can say 5Q5 is valued expensively.
Industry RankSector Rank
PE 192.89
Fwd PE 136.47
5Q5.DE Price Earnings VS Forward Price Earnings5Q5.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, 5Q5 is valued a bit more expensive than 73.85% of the companies in the same industry.
Industry RankSector Rank
P/FCF 59.71
EV/EBITDA N/A
5Q5.DE Per share data5Q5.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
5Q5's earnings are expected to grow with 40.20% in the coming years. This may justify a more expensive valuation.
PEG (NY)4.68
PEG (5Y)N/A
EPS Next 2Y40.09%
EPS Next 3Y40.2%

0

5. Dividend

5.1 Amount

5Q5 does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

SNOWFLAKE INC-CLASS A

FRA:5Q5 (4/25/2025, 7:00:00 PM)

138.88

+2.22 (+1.62%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)02-26 2025-02-26/amc
Earnings (Next)05-21 2025-05-21/amc
Inst Owners65.18%
Inst Owner ChangeN/A
Ins Owners3.14%
Ins Owner ChangeN/A
Market Cap46.40B
Analysts80.38
Price Target182.27 (31.24%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)48.7%
Min EPS beat(2)28.68%
Max EPS beat(2)68.73%
EPS beat(4)3
Avg EPS beat(4)21.05%
Min EPS beat(4)-24.62%
Max EPS beat(4)68.73%
EPS beat(8)7
Avg EPS beat(8)65.23%
EPS beat(12)10
Avg EPS beat(12)114.11%
EPS beat(16)14
Avg EPS beat(16)125.06%
Revenue beat(2)2
Avg Revenue beat(2)2.08%
Min Revenue beat(2)1.2%
Max Revenue beat(2)2.97%
Revenue beat(4)4
Avg Revenue beat(4)1.9%
Min Revenue beat(4)0.06%
Max Revenue beat(4)3.38%
Revenue beat(8)7
Avg Revenue beat(8)1.11%
Revenue beat(12)11
Avg Revenue beat(12)1.26%
Revenue beat(16)15
Avg Revenue beat(16)2.05%
PT rev (1m)-2.66%
PT rev (3m)5.83%
EPS NQ rev (1m)0.4%
EPS NQ rev (3m)11.22%
EPS NY rev (1m)17.12%
EPS NY rev (3m)14.7%
Revenue NQ rev (1m)0.1%
Revenue NQ rev (3m)0.39%
Revenue NY rev (1m)0.11%
Revenue NY rev (3m)1.35%
Valuation
Industry RankSector Rank
PE 192.89
Fwd PE 136.47
P/S 14.56
P/FCF 59.71
P/OCF 55
P/B 17.6
P/tB 31.7
EV/EBITDA N/A
EPS(TTM)0.72
EY0.52%
EPS(NY)1.02
Fwd EY0.73%
FCF(TTM)2.33
FCFY1.67%
OCF(TTM)2.53
OCFY1.82%
SpS9.54
BVpS7.89
TBVpS4.38
PEG (NY)4.68
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -14.23%
ROE -42.86%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 66.72%
FCFM 24.38%
ROA(3y)-11.57%
ROA(5y)-10.81%
ROE(3y)-24.53%
ROE(5y)-19.6%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.25%
GM growth 5Y3.57%
F-Score4
Asset Turnover0.4
Health
Industry RankSector Rank
Debt/Equity 0.76
Debt/FCF 2.57
Debt/EBITDA N/A
Cap/Depr 41.48%
Cap/Sales 2.09%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.78
Quick Ratio 1.78
Altman-Z N/A
F-Score4
WACC9.15%
ROIC/WACCN/A
Cap/Depr(3y)67.2%
Cap/Depr(5y)189.29%
Cap/Sales(3y)2.66%
Cap/Sales(5y)4.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-15.46%
EPS 3Y334.45%
EPS 5YN/A
EPS Q2Q%-14.29%
EPS Next Y41.19%
EPS Next 2Y40.09%
EPS Next 3Y40.2%
EPS Next 5Y40.68%
Revenue 1Y (TTM)29.21%
Revenue growth 3Y43.81%
Revenue growth 5Y68.79%
Sales Q2Q%27.37%
Revenue Next Year24.48%
Revenue Next 2Y23.57%
Revenue Next 3Y23.75%
Revenue Next 5Y22.4%
EBIT growth 1Y-31.05%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year192%
EBIT Next 3Y83.5%
EBIT Next 5Y79.48%
FCF growth 1Y17.85%
FCF growth 3Y149.53%
FCF growth 5YN/A
OCF growth 1Y13.16%
OCF growth 3Y105.74%
OCF growth 5YN/A